Dormancy signatures and metastasis in estrogen receptor positive and negative breast cancer.
Ontology highlight
ABSTRACT: Breast cancers can recur after removal of the primary tumor and treatment to eliminate remaining tumor cells. Recurrence may occur after long periods of time during which there are no clinical symptoms. Tumor cell dormancy may explain these prolonged periods of asymptomatic residual disease and treatment resistance. We generated a dormancy gene signature from published experimental models and applied it to both breast cancer cell line expression data as well as four published clinical studies of primary breast cancers. We found that estrogen receptor (ER) positive breast cell lines and primary tumors have significantly higher dormancy signature scores (P<0.0000001) than ER- cell lines and tumors. In addition, a stratified analysis combining all ER+ tumors in four studies indicated 2.1 time
SUBMITTER: Kim RS
PROVIDER: S-EPMC3329481 | biostudies-literature | 2012
REPOSITORIES: biostudies-literature
ACCESS DATA